2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride has been researched along with sesquiterpenes in 1 studies
| Studies (2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride) | Trials (2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride) | Recent Studies (post-2010) (2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride) | Studies (sesquiterpenes) | Trials (sesquiterpenes) | Recent Studies (post-2010) (sesquiterpenes) |
|---|---|---|---|---|---|
| 10 | 0 | 0 | 17,489 | 536 | 7,668 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, DK; Hancock, WW; Kobayashi, T; Koren, E; Neethling, FA; Niekrasz, M; Takagi, H; Taniguchi, S; Ye, Y | 1 |
1 other study(ies) available for 2-methyl-3-(4-phenylpiperidino)propionohydroxamic acid hydrochloride and sesquiterpenes
| Article | Year |
|---|---|
In vitro and in vivo investigation of anticomplement agents FUT-175 and K76COOH, in the prevention of hyperacute rejection following discordant xenotransplantation in a nonhuman primate model.
Topics: Animals; Benzamidines; Cells, Cultured; Complement Inactivator Proteins; Cytotoxicity, Immunologic; Graft Rejection; Graft Survival; Guanidines; Hydroxamic Acids; Kidney; Kidney Transplantation; Papio; Sesquiterpenes; Swine | 1996 |